Hypersensitivity reaction to balsalazide.
نویسندگان
چکیده
need, however, to be interpreted with caution: it is possible that shorter pupils are simply more likely to mistake the normal rough and tumble in the playground for bullying. The data could also be accounted for by the fact that significantly fewer control than short boys admitted to being bullied. Even when they did, few confessed to being upset. Around one in four short victims, girls as well as boys, were both victims and bullies; from the reported association between bullying, physical size, and sex, it might have been expected that few short pupils and even fewer short girls would bully others. 3 Are some of these the so called provocative victims for whom any reaction, however painful, is preferable to being ignored? Pupils do not always tell parents or teachers when they are being bullied, and this report may serve to alert parents and teachers to potential bullies as well as victims. As Olweus reminds us, “Every individual should have the right to be spared oppression and repeated, intentional humiliation, in school as in society at large.” We thank Drs A D Roberts and R Stratford, department of psychology, and Dr R Pickering, department of medical statistics and computing, University of Southampton, for their help and advice and Bruce Downie for interviewing all the parents. Contributors: LDV designed the protocol, revised and administered the questionnaires, and wrote the paper. JM carried out the statistical analysis and contributed to the interpretation of the results. LDV will act as guarantor for the paper. Funding: The Wessex growth study has been supported by a research and development grant from the South and West regional office of the NHS Executive and by a grant from the Child Research Fund, Liverpool, and see below. Competing interests: The Wessex growth study has been supported by a grant from Pharmacia Upjohn to the Wessex Medical Trust.
منابع مشابه
Drug points: Hypersensitivity reaction to balsalazide.
Balsalazide is used in short term and maintenance treatment of ulcerative colitis. It is a prodrug in which 5-aminosalicylic acid is linked via a diazo bond to 4-aminobenzoyl-â-alanine, an inert and biologically inactive carrier molecule. We report a case of a hypersensitivity reaction to balsalazide, involving pericarditis, an abnormal liver biochemistry profile, and splinter haemorrhages. A 5...
متن کاملPharmacokinetics for Balsalazide and Key Metabolites (5—ASA and N-Ac-5- ASA) with Administration of COLAZAL Following a Fast, a High-Fat Meal, and Drug Contents
COLAZAL (balsalazide disodium) Capsules (kôl a zal) DESCRIPTION: Each COLAZAL capsule contains 750 mg of balsalazide disodium, a prodrug that is enzymatically cleaved in the colon to produce mesalamine (5-aminosalicylic acid or 5-ASA), an antiinflammatory drug. Each daily dose of COLAZAL (6.75 grams) is equivalent to 2.4 grams of mesalamine. Balsalazide disodium has the chemical name (E)-5-[[-4...
متن کاملMetal Hypersensitivity in Orthodontic Patients
Orthodontic treatment of individuals with metal hypersensitivity is a matter of concern for the orthodontist. Orthodontic appliances contain metals like Nickel, Cobalt and Chromium etc. Metals may cause allergic reactions and are known as allergens. Reaction to these metals is due to biodegradation of metals in the oral cavity. This may lead to the formation of corrosion products and their expo...
متن کاملHypersensitivity Reaction to Local Anesthetic in Dentistry: A Case Report
Background and Aim: Local anesthesia plays an important role in dentistry. Although hypersensitivity reactions to local anesthetic drugs are rare,but they are more common in dental cartridge components. This study reports a rare case of hypersensitivity to components of local anesthesia cartridge. Case Report: A 61-year-old female patient referred to The Medical Council to complain the dentist ...
متن کاملLow dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
BACKGROUND Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug. Its efficacy in comparison with standard mesalazine therapy and the optimum dose for maintaining remission of ulcerative colitis are still unclear. AIMS To compare the relapse preventing effect and safety profile of two doses of balsalazide and a standard dose of Eudragit coated mesalazine. METHODS A total of ...
متن کاملBalsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
BACKGROUND/AIMS Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-κB (NF-κB) activity. Parthenolide (PT) inhibits NF-κB and exerts promising anticancer effects by promoting apoptosis. The present investigated the antitumor effects of balsalazid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 320 7235 شماره
صفحات -
تاریخ انتشار 2000